Recent Product Recalls - Pharmaceutical & Medical Device Regulatory Update, Vol. II, Issue 4

JD
Jones Day

Contributor

Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
Injection drug products continued to be recalled for various issues.
United States Food, Drugs, Healthcare, Life Sciences

Injection drug products continued to be recalled for various issues. In recent weeks, two injection drug products were recalled, one for potential sterility issues and a second because consumers observed particulates floating in some of the vials. Additionally, a medical device manufacturer that had recalled a peripheral infusion system in December 2014, due to a device error that arose from incorrect labeling, issued a second notice stating that the recall has now been classified by FDA as Class I.

View a complete listing of FDA Recalls.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More